EUR 643.95 For Business Accounts Only

Applied BioCode Inc - Product Pipeline Analysis, 2020 Update

Summary

Applied BioCode Inc (Applied BioCode) is a medical device company that develops, manufactures, and commercializes multiplex testing products. The company provides a digital multiplexing molecular platform that delivers multiplex analysis for the research of moleculars and proteins. It offers BioCode MDx 3000 System, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and BioCode 2500 Analyzer, a system for multiplex applications. Applied BioCode offers BioCode gastrointestinal pathogen panel for common gastrointestinal pathogen including viruses, bacteria, and parasites that cause infectious diarrhea; and BioCode sexually transmitted infections (STI) panel for the detection of common infectious agents causing STDs. The company also provides a multiplex cytokine and chemokine detection panel to identify biomarkers; mouse cytokine and chemokine multiplex kits that allow users to pick and choose their own analytes panels; pre-mixed and custom multiplex kits; barcoded magnetic beads for bioassay applications; calibration beads to coupling kits; and assay development, AgBio application, and multiplex ELISA assay services. Applied BioCode is headquartered in Santa Fe Springs, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Applied BioCode Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company